JPH0558631B2 - - Google Patents

Info

Publication number
JPH0558631B2
JPH0558631B2 JP62018790A JP1879087A JPH0558631B2 JP H0558631 B2 JPH0558631 B2 JP H0558631B2 JP 62018790 A JP62018790 A JP 62018790A JP 1879087 A JP1879087 A JP 1879087A JP H0558631 B2 JPH0558631 B2 JP H0558631B2
Authority
JP
Japan
Prior art keywords
formula
oxo
pyrrolidin
salts
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP62018790A
Other languages
English (en)
Japanese (ja)
Other versions
JPS62185068A (ja
Inventor
Bentsue Uiriamu
Furuusutoru Uorufugangu
Uiruherumu Matsukusu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of JPS62185068A publication Critical patent/JPS62185068A/ja
Publication of JPH0558631B2 publication Critical patent/JPH0558631B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
JP62018790A 1986-01-30 1987-01-30 置換ピロリジン―2―オン化合物、その製造方法及びそれを含む向知性薬 Granted JPS62185068A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH346/86-6 1986-01-30
CH34686 1986-01-30

Publications (2)

Publication Number Publication Date
JPS62185068A JPS62185068A (ja) 1987-08-13
JPH0558631B2 true JPH0558631B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-08-27

Family

ID=4184917

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62018790A Granted JPS62185068A (ja) 1986-01-30 1987-01-30 置換ピロリジン―2―オン化合物、その製造方法及びそれを含む向知性薬

Country Status (21)

Country Link
US (1) US4945092A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0236263B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS62185068A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR870007159A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE84033T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU599951B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1312081C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD260066A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3783247D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK47187A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2053578T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI870329A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3007411T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU202862B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE61100B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL81394A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO870374L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ219101A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH23078A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT84204B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA87650B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
US20040180925A1 (en) * 2000-12-27 2004-09-16 Kenji Matsuno Dipeptidylpeptidase-IV inhibitor
EP4101561A1 (de) 2021-06-08 2022-12-14 Meusburger Georg GmbH & Co. KG Zentriereinrichtung für ein formwerkzeug mit gleichzeitig tragenden wälzkörpereinheiten

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
US4144246A (en) * 1976-11-15 1979-03-13 Parke, Davis & Company Pyrrolidineacetic acid esters
BE864269A (fr) * 1977-03-03 1978-06-16 Parke Davis & Co Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire
DE2757680A1 (de) * 1977-12-23 1979-06-28 Troponwerke Gmbh & Co Kg Neue 2-oxo-1-pyrrolidinessigsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0089900B1 (en) * 1982-03-24 1985-12-27 Prodes S.A. New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts

Also Published As

Publication number Publication date
ATE84033T1 (de) 1993-01-15
EP0236263A2 (de) 1987-09-09
IE870230L (en) 1987-07-30
HU202862B (en) 1991-04-29
NZ219101A (en) 1990-03-27
IL81394A (en) 1991-08-16
DK47187D0 (da) 1987-01-29
JPS62185068A (ja) 1987-08-13
GR3007411T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-07-30
EP0236263B1 (de) 1992-12-30
EP0236263A3 (en) 1989-04-19
PT84204A (en) 1987-02-01
ZA87650B (en) 1987-09-30
DE3783247D1 (de) 1993-02-11
KR870007159A (ko) 1987-08-17
AU599951B2 (en) 1990-08-02
AU6809787A (en) 1987-08-06
DK47187A (da) 1987-07-31
FI870329A0 (fi) 1987-01-26
US4945092A (en) 1990-07-31
NO870374L (no) 1987-07-31
HUT43058A (en) 1987-09-28
CA1312081C (en) 1992-12-29
PT84204B (pt) 1989-09-14
DD260066A5 (de) 1988-09-14
IE61100B1 (en) 1994-10-05
NO870374D0 (no) 1987-01-29
ES2053578T3 (es) 1994-08-01
IL81394A0 (en) 1987-08-31
FI870329A7 (fi) 1987-07-31
PH23078A (en) 1989-04-10

Similar Documents

Publication Publication Date Title
BE1006343A5 (fr) Derives de l'indole.
FI70406B (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva karbazolyl-(4)-oxi-propanolamin-derivat
JPH0780871B2 (ja) 新規4―ベンジル―1―(2h)―フタラジノン―誘導体及びその製法
JPH0558631B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US4011238A (en) 2-imidazolidione derivatives
WO1999062900A1 (fr) Derives d'oxindole utile comme antagonistes des recepteurs de neurokinines
FI80261B (fi) Foerfarande foer optisk upploesning av en blandning av enantiomerer av trans-3-/(4-metoxifenoxi)-metyl/-1-metyl-4- fenylpiperidin.
AU2003269331B2 (en) acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one having neuroleptic activity
JPS59118775A (ja) アラルキルトリアゾ−ル化合物
JPS58116434A (ja) 置換されたフエノキシアルカノ−ルアミン類及びフエノキシアルカノ−ル−シクロアルキルアミン類
JPH034073B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0125315A1 (en) Phenoxyaminopropanol derivatives
CA2217171C (en) New process for preparing (-)-trans-n-p-fluorobenzoylmethyl-4-(p-fluorophenyl)-3-¢¢3,4-(methylenedioxy)phenoxy!methyl!-piperidine
CA1039728A (en) Reserpine derivatives
US3117963A (en) A-phenylbenzyl
EP0133259A2 (en) Aminoalkyl-substituted benzene derivatives, process for production thereof, and pharmaceutical composition thereof
SU528870A3 (ru) Способ получени производных 2-имидазолидинона или их солей
JP3159518B2 (ja) アミノ置換スピロ化合物の製法
JPS6024100B2 (ja) アミノプロパノ−ル−誘導体の製法
FI71313B (fi) Analogifoerfarande foer framstaellning av terapeutiskt anvaenbar 2-(1-fenylbensimidazolyl)acetohydroxamsyra
JP2921933B2 (ja) 光学活性酪酸誘導体
DE60202554T2 (de) Benzolsulfonamidderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
US3900515A (en) 2-aryl-3-isopropylamino-1-butanols
KR860000590B1 (ko) 4-(5-클로로-2-옥소벤즈이미다졸린-1-일)-1-[3-(2-옥소벤즈이미다졸린-1-일)프로필]-피페리딘 및 그 염의 제조방법
SU1147250A3 (ru) Способ получени производных 4-оксоазетидин-2,2-дикарбоновой кислоты